Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 426.04MTangible Assets
VS
Market
Sector
Industry
History
$ 14.26Close
$ 8.21 - $ 14.6 52-Week Range
Ticker Information
Ticker
TBPHCompany Name
THERAVANCE BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTHERAVANCE BIOPHARMA INC - Tangible Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TBPH - Tangible Assets Historical data
| Date | Total Assets | Goodwill and Intangibles | Tangible Assets |
|---|---|---|---|
| 6/30/2025 | $ 426.04M | $ 0 | $ 426.04M |
| 3/31/2025 | $ 343.58M | $ 0 | $ 343.58M |
| 12/31/2024 | $ 354.16M | $ 0 | $ 354.16M |
| 9/30/2024 | $ 356.11M | $ 0 | $ 356.11M |
| 6/30/2024 | $ 362.03M | $ 0 | $ 362.03M |
| 3/31/2024 | $ 371.31M | $ 0 | $ 371.31M |
| 12/31/2023 | $ 382M | $ 0 | $ 382M |
| 9/30/2023 | $ 413.59M | $ 0 | $ 413.59M |
| 6/30/2023 | $ 446.63M | $ 0 | $ 446.63M |
| 3/31/2023 | $ 538.55M | $ 0 | $ 538.55M |
Key Performance Insights, Last 5 Years
- THERAVANCE BIOPHARMA INC's latest trailing twelve months (TTM) Tangible Assets stands at $ 512.19M.
- Over the past 5 years, THERAVANCE BIOPHARMA INC's average Tangible Assets has been $ 432.23M.
- The median Tangible Assets for THERAVANCE BIOPHARMA INC during this period was $ 392.55M
- THERAVANCE BIOPHARMA INC reached its highest Tangible Assets over the past 5 years at $ 763.5M.
- The lowest Tangible Assets recorded by THERAVANCE BIOPHARMA INC in the same timeframe $ 343.58M
THERAVANCE BIOPHARMA INC's Tangible Assets vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Tangible Assets Benchmarks
Similar metrics to Tangible Assets:
- Goodwill & Intangibles to Assets Ratio - [Calculation] The [Intangibles] to [Assets] ratio is used as a company valuation factor by investors. Goodwill & Intangibles represent hard-to-value assets like a company’s brand name, solid customer relations, intellectual property, etc.
- Core Assets - [Calculation] The core assets of a company represents the total [Assets] minus cash & equivalents [CashnEq] minus intangibles & goodwill [Intangibles].
- Goodwill and Intangibles - [Balance Sheet] Goodwill and Intangible Assets are a component of [Assets] representing nonphysical assets like goodwill, patents, trademarks, and copyrights; net of accumulated amortization and impairment charges.
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Inventory to Assets Ratio - [Calculation] [Inventory] as percentage of total [Assets], serves as an efficiency ratio - the lower the better.
Definition of Tangible Assets
[Calculation] A tangible asset is an asset that has physical substance. Typical examples may include [Inventory], equipment or machinery an property. It is calculated by subtracting intangibles & goodwill [Intangibles] from total [Assets].Assets - Intangibles
(=) Tangible Assets Tangible Assets for THERAVANCE BIOPHARMA INC is calculated as follows: Assets [ $ 512.19M ] - Intangibles [ $ 0 ]
(=) Tangible Assets [ $ 512.19M ] TBPH - Tangible Assets, Last 5 years
$ 343.58M
Minimum
Mar 31, 2025
$ 763.5M
Maximum
Sep 30, 2022
$ 432.23M
Average
$ 392.55M
Median
Tangible Assets Benchmark AnalysisMarket
The chart above depicts the distribution of Tangible Assets for companies in the Total Stock Market. The average Tangible Assets of the companies is $ 996.29M with a standard deviation of $ 1.28B.
The following table provides additional summary stats:
Tangible Assets in the Market:
| filtered constituents | 3.47K |
|---|---|
| min | $ 0 |
| max | $ 5.31B |
| average | $ 996.29M |
| median | $ 389.26M |
| std | $ 1.28B |